can i stop taking tirzepatide Dosing TIRZEPATIDE WITHDRAWAL | What happens

Singh R, Bansal Y, Medhi B, Kuhad A

The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease

Specifically, the inclusion of the SURPASS-CVOT trial, which compares tirzepatide against dulaglutide rather than semaglutide, is explicitly justified as it provides vital contextual cardiovascular outcome data for tirzepatide in the absence of a completed head-to-head cardiovascular trial between the two primary agents

Bray JJH, Foster-Davies H, Salem A, et al

Any decision involving injectable peptides should be discussed with a licensed medical professional who can assess individual risk factors

Liver cancer was defined as primary liver malignancy, including hepatocellular carcinoma, and the term liver cancer is used consistently throughout the manuscript